|
||||
Public Act 096-0347 |
||||
| ||||
| ||||
AN ACT concerning criminal law.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The Illinois Controlled Substances Act is | ||||
amended by changing Sections 204, 401, and 402 as follows:
| ||||
(720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
| ||||
Sec. 204. (a) The controlled substances listed in this | ||||
Section are
included in Schedule I.
| ||||
(b) Unless specifically excepted or unless listed in | ||||
another
schedule, any of the following opiates, including their | ||||
isomers,
esters, ethers, salts, and salts of isomers, esters, | ||||
and ethers,
whenever the existence of such isomers, esters, | ||||
ethers and salts is
possible within the specific chemical | ||||
designation:
| ||||
(1) Acetylmethadol;
| ||||
(1.1) Acetyl-alpha-methylfentanyl
| ||||
(N-[1-(1-methyl-2-phenethyl)-
| ||||
4-piperidinyl]-N-phenylacetamide);
| ||||
(2) Allylprodine;
| ||||
(3) Alphacetylmethadol, except
| ||||
levo-alphacetylmethadol (also known as levo-alpha-
| ||||
acetylmethadol, levomethadyl acetate, or LAAM);
| ||||
(4) Alphameprodine;
|
(5) Alphamethadol;
| ||
(6) Alpha-methylfentanyl
| ||
(N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
| ||
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
| ||
propanilido) piperidine;
| ||
(6.1) Alpha-methylthiofentanyl
| ||
(N-[1-methyl-2-(2-thienyl)ethyl-
| ||
4-piperidinyl]-N-phenylpropanamide);
| ||
(7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
| ||
(7.1) PEPAP
| ||
(1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
| ||
(8) Benzethidine;
| ||
(9) Betacetylmethadol;
| ||
(9.1) Beta-hydroxyfentanyl
| ||
(N-[1-(2-hydroxy-2-phenethyl)-
| ||
4-piperidinyl]-N-phenylpropanamide);
| ||
(10) Betameprodine;
| ||
(11) Betamethadol;
| ||
(12) Betaprodine;
| ||
(13) Clonitazene;
| ||
(14) Dextromoramide;
| ||
(15) Diampromide;
| ||
(16) Diethylthiambutene;
| ||
(17) Difenoxin;
| ||
(18) Dimenoxadol;
| ||
(19) Dimepheptanol;
|
(20) Dimethylthiambutene;
| ||
(21) Dioxaphetylbutyrate;
| ||
(22) Dipipanone;
| ||
(23) Ethylmethylthiambutene;
| ||
(24) Etonitazene;
| ||
(25) Etoxeridine;
| ||
(26) Furethidine;
| ||
(27) Hydroxpethidine;
| ||
(28) Ketobemidone;
| ||
(29) Levomoramide;
| ||
(30) Levophenacylmorphan;
| ||
(31) 3-Methylfentanyl
| ||
(N-[3-methyl-1-(2-phenylethyl)-
| ||
4-piperidyl]-N-phenylpropanamide);
| ||
(31.1) 3-Methylthiofentanyl
| ||
(N-[(3-methyl-1-(2-thienyl)ethyl-
| ||
4-piperidinyl]-N-phenylpropanamide);
| ||
(32) Morpheridine;
| ||
(33) Noracymethadol;
| ||
(34) Norlevorphanol;
| ||
(35) Normethadone;
| ||
(36) Norpipanone;
| ||
(36.1) Para-fluorofentanyl
| ||
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
| ||
4-piperidinyl]propanamide);
| ||
(37) Phenadoxone;
|
(38) Phenampromide;
| ||
(39) Phenomorphan;
| ||
(40) Phenoperidine;
| ||
(41) Piritramide;
| ||
(42) Proheptazine;
| ||
(43) Properidine;
| ||
(44) Propiram;
| ||
(45) Racemoramide;
| ||
(45.1) Thiofentanyl
| ||
(N-phenyl-N-[1-(2-thienyl)ethyl-
| ||
4-piperidinyl]-propanamide);
| ||
(46) Tilidine;
| ||
(47) Trimeperidine;
| ||
(48) Beta-hydroxy-3-methylfentanyl (other name:
| ||
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
| ||
N-phenylpropanamide).
| ||
(c) Unless specifically excepted or unless listed in | ||
another
schedule, any of the following opium derivatives, its | ||
salts, isomers
and salts of isomers, whenever the existence of | ||
such salts, isomers and
salts of isomers is possible within the | ||
specific chemical designation:
| ||
(1) Acetorphine;
| ||
(2) Acetyldihydrocodeine;
| ||
(3) Benzylmorphine;
| ||
(4) Codeine methylbromide;
| ||
(5) Codeine-N-Oxide;
|
(6) Cyprenorphine;
| ||
(7) Desomorphine;
| ||
(8) Diacetyldihydromorphine (Dihydroheroin);
| ||
(9) Dihydromorphine;
| ||
(10) Drotebanol;
| ||
(11) Etorphine (except hydrochloride salt);
| ||
(12) Heroin;
| ||
(13) Hydromorphinol;
| ||
(14) Methyldesorphine;
| ||
(15) Methyldihydromorphine;
| ||
(16) Morphine methylbromide;
| ||
(17) Morphine methylsulfonate;
| ||
(18) Morphine-N-Oxide;
| ||
(19) Myrophine;
| ||
(20) Nicocodeine;
| ||
(21) Nicomorphine;
| ||
(22) Normorphine;
| ||
(23) Pholcodine;
| ||
(24) Thebacon.
| ||
(d) Unless specifically excepted or unless listed in | ||
another
schedule, any material, compound, mixture, or | ||
preparation which contains
any quantity of the following | ||
hallucinogenic substances, or which
contains any of its salts, | ||
isomers and salts of isomers, whenever the
existence of such | ||
salts, isomers, and salts of isomers is possible
within the | ||
specific chemical designation (for the purposes of this
|
paragraph only, the term "isomer" includes the optical, | ||
position and
geometric isomers):
| ||
(1) 3,4-methylenedioxyamphetamine
| ||
(alpha-methyl,3,4-methylenedioxyphenethylamine,
| ||
methylenedioxyamphetamine, MDA);
| ||
(1.1) Alpha-ethyltryptamine
| ||
(some trade or other names: etryptamine;
| ||
MONASE; alpha-ethyl-1H-indole-3-ethanamine;
| ||
3-(2-aminobutyl)indole; a-ET; and AET);
| ||
(2) 3,4-methylenedioxymethamphetamine (MDMA);
| ||
(2.1) 3,4-methylenedioxy-N-ethylamphetamine
| ||
(also known as: N-ethyl-alpha-methyl-
| ||
3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
| ||
and MDEA);
| ||
(2.2) N-Benzylpiperazine (BZP);
| ||
(3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
| ||
(4) 3,4,5-trimethoxyamphetamine (TMA);
| ||
(5) (Blank);
| ||
(6) Diethyltryptamine (DET);
| ||
(7) Dimethyltryptamine (DMT);
| ||
(8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
| ||
(9) Ibogaine (some trade and other names:
| ||
7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
| ||
6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
| ||
indole; Tabernanthe iboga);
| ||
(10) Lysergic acid diethylamide;
|
(10.5) Salvia divinorum (meaning all parts of the plant | ||
presently classified
botanically as Salvia divinorum, | ||
whether growing or not, the
seeds thereof, any extract from | ||
any part of that plant, and every compound,
manufacture, | ||
salts, isomers, and salts of
isomers whenever the existence | ||
of such salts, isomers, and salts of
isomers is possible | ||
within the specific chemical designation, derivative, | ||
mixture, or preparation of that plant, its
seeds or | ||
extracts);
| ||
(11) 3,4,5-trimethoxyphenethylamine (Mescaline);
| ||
(12) Peyote (meaning all parts of the plant presently | ||
classified
botanically as Lophophora williamsii
Lemaire, | ||
whether growing or not, the
seeds thereof, any extract from | ||
any part of that plant, and every compound,
manufacture, | ||
salts, derivative, mixture, or preparation of that plant, | ||
its
seeds or extracts);
| ||
(13) N-ethyl-3-piperidyl benzilate (JB 318);
| ||
(14) N-methyl-3-piperidyl benzilate;
| ||
(14.1) N-hydroxy-3,4-methylenedioxyamphetamine
| ||
(also known as N-hydroxy-alpha-methyl-
| ||
3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
| ||
(15) Parahexyl; some trade or other names:
| ||
3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
| ||
dibenzo (b,d) pyran; Synhexyl;
| ||
(16) Psilocybin;
| ||
(17) Psilocyn;
|
(18) Alpha-methyltryptamine (AMT);
| ||
(19) 2,5-dimethoxyamphetamine
| ||
(2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
| ||
(20) 4-bromo-2,5-dimethoxyamphetamine
| ||
(4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
| ||
4-bromo-2,5-DMA);
| ||
(20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
| ||
Some trade or other names: 2-(4-bromo-
| ||
2,5-dimethoxyphenyl)-1-aminoethane;
| ||
alpha-desmethyl DOB, 2CB, Nexus;
| ||
(21) 4-methoxyamphetamine
| ||
(4-methoxy-alpha-methylphenethylamine;
| ||
paramethoxyamphetamine; PMA);
| ||
(22) (Blank);
| ||
(23) Ethylamine analog of phencyclidine.
| ||
Some trade or other names:
| ||
N-ethyl-1-phenylcyclohexylamine,
| ||
(1-phenylcyclohexyl) ethylamine,
| ||
N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
| ||
(24) Pyrrolidine analog of phencyclidine. Some trade | ||
or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, | ||
PHP;
| ||
(25) 5-methoxy-3,4-methylenedioxy-amphetamine;
| ||
(26) 2,5-dimethoxy-4-ethylamphetamine
| ||
(another name: DOET);
| ||
(27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
(another name: TCPy);
| ||
(28) (Blank);
| ||
(29) Thiophene analog of phencyclidine (some trade
| ||
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
| ||
2-thienyl analog of phencyclidine; TPCP; TCP);
| ||
(30) Bufotenine (some trade or other names:
| ||
3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
| ||
3-(2-dimethylaminoethyl)-5-indolol;
| ||
5-hydroxy-N,N-dimethyltryptamine;
| ||
N,N-dimethylserotonin; mappine).
| ||
(e) Unless specifically excepted or unless listed in | ||
another
schedule, any material, compound, mixture, or | ||
preparation which contains
any quantity of the following | ||
substances having a depressant effect on
the central nervous | ||
system, including its salts, isomers, and salts of
isomers | ||
whenever the existence of such salts, isomers, and salts of
| ||
isomers is possible within the specific chemical designation:
| ||
(1) mecloqualone;
| ||
(2) methaqualone; and
| ||
(3) gamma hydroxybutyric acid.
| ||
(f) Unless specifically excepted or unless listed in | ||
another schedule,
any material, compound, mixture, or | ||
preparation which contains any quantity
of the following | ||
substances having a stimulant effect on the central nervous
| ||
system, including its salts, isomers, and salts of isomers:
| ||
(1) Fenethylline;
|
(2) N-ethylamphetamine;
| ||
(3) Aminorex (some other names:
| ||
2-amino-5-phenyl-2-oxazoline; aminoxaphen;
| ||
4-5-dihydro-5-phenyl-2-oxazolamine) and its
| ||
salts, optical isomers, and salts of optical isomers;
| ||
(4) Methcathinone (some other names:
| ||
2-methylamino-1-phenylpropan-1-one;
| ||
Ephedrone; 2-(methylamino)-propiophenone;
| ||
alpha-(methylamino)propiophenone; N-methylcathinone;
| ||
methycathinone; Monomethylpropion; UR 1431) and its
| ||
salts, optical isomers, and salts of optical isomers;
| ||
(5) Cathinone (some trade or other names:
| ||
2-aminopropiophenone; alpha-aminopropiophenone;
| ||
2-amino-1-phenyl-propanone; norephedrone);
| ||
(6) N,N-dimethylamphetamine (also known as:
| ||
N,N-alpha-trimethyl-benzeneethanamine;
| ||
N,N-alpha-trimethylphenethylamine);
| ||
(7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
| ||
4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
| ||
(g) Temporary listing of substances subject to emergency | ||
scheduling.
Any material, compound, mixture, or preparation | ||
that contains any quantity
of the following substances:
| ||
(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
| ||
(benzylfentanyl), its optical isomers, isomers, salts,
| ||
and salts of isomers;
| ||
(2) N-[1(2-thienyl)
|
methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
| ||
its optical isomers, salts, and salts of isomers.
| ||
(Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07.)
| ||
(720 ILCS 570/401) (from Ch. 56 1/2, par. 1401)
| ||
Sec. 401. Except as authorized by this Act, it is unlawful | ||
for any
person knowingly to manufacture or deliver, or possess | ||
with intent to
manufacture or deliver, a controlled substance | ||
other than methamphetamine, a counterfeit substance, or a | ||
controlled
substance analog. A violation of this Act with | ||
respect to each of the controlled
substances listed herein | ||
constitutes a single and separate violation of this
Act. For | ||
purposes of this Section, "controlled substance analog" or | ||
"analog"
means a substance
which is intended for human | ||
consumption, other than a controlled substance,
that has a | ||
chemical structure substantially similar to that of a | ||
controlled
substance in Schedule I or II, or that was | ||
specifically designed to produce
an effect substantially | ||
similar to that of a controlled substance in Schedule
I or II. | ||
Examples of chemical classes in which controlled substance | ||
analogs
are found include, but are not limited to, the | ||
following: phenethylamines,
N-substituted piperidines, | ||
morphinans, ecgonines, quinazolinones, substituted
indoles, | ||
and arylcycloalkylamines. For purposes of this Act, a | ||
controlled
substance analog shall be treated in the same manner | ||
as the controlled
substance to which it is substantially |
similar.
| ||
(a) Any person who violates this Section with respect to | ||
the following
amounts of controlled or counterfeit substances | ||
or controlled substance
analogs, notwithstanding any of the | ||
provisions of subsections (c),
(d), (e), (f), (g) or (h) to the | ||
contrary, is guilty of a Class X felony
and shall be sentenced | ||
to a term of imprisonment as provided in this subsection
(a) | ||
and fined as provided in subsection (b):
| ||
(1) (A) not less than 6 years and not more than 30 | ||
years with respect
to 15 grams or more but less than | ||
100 grams of a substance containing
heroin, or an | ||
analog thereof;
| ||
(B) not less than 9 years and not more than 40 | ||
years with respect to 100
grams or more but less than | ||
400 grams of a substance containing heroin, or
an | ||
analog thereof;
| ||
(C) not less than 12 years and not more than 50 | ||
years with respect to
400 grams or more but less than | ||
900 grams of a substance containing heroin,
or an | ||
analog thereof;
| ||
(D) not less than 15 years and not more than 60 | ||
years with respect to
900 grams or more of any | ||
substance containing heroin, or an analog thereof;
| ||
(1.5) (A) not less than 6 years and not more than 30 | ||
years with respect to 15 grams or more but less than | ||
100 grams of a substance containing fentanyl, or an |
analog thereof;
| ||
(B) not less than 9 years and not more than 40 | ||
years with respect to 100 grams or more but less than | ||
400 grams of a substance containing fentanyl, or an | ||
analog thereof; | ||
(C) not less than 12 years and not more than 50 | ||
years with respect to 400 grams or more but less than | ||
900 grams of a substance containing fentanyl, or an | ||
analog thereof; | ||
(D) not less than 15 years and not more than 60 | ||
years with respect to 900 grams or more of a substance | ||
containing fentanyl, or an analog thereof;
| ||
(2) (A) not less than 6 years and not more than 30 | ||
years with respect
to 15 grams or more but less than | ||
100 grams of a substance containing
cocaine, or an | ||
analog thereof;
| ||
(B) not less than 9 years and not more than 40 | ||
years with respect to 100
grams or more but less than | ||
400 grams of a substance containing cocaine, or
an | ||
analog thereof;
| ||
(C) not less than 12 years and not more than 50 | ||
years with respect to
400 grams or more but less than | ||
900 grams of a substance containing cocaine,
or an | ||
analog thereof;
| ||
(D) not less than 15 years and not more than 60 | ||
years with respect to
900 grams or more of any |
substance containing cocaine, or an analog thereof;
| ||
(3) (A) not less than 6 years and not more than 30 | ||
years with respect
to 15 grams or more but less than | ||
100 grams of a substance containing
morphine, or an | ||
analog thereof;
| ||
(B) not less than 9 years and not more than 40 | ||
years with respect to
100 grams or more but less than | ||
400 grams of a substance containing morphine,
or an | ||
analog thereof;
| ||
(C) not less than 12 years and not more than 50 | ||
years with respect to
400 grams or more but less than | ||
900 grams of a substance containing
morphine, or an | ||
analog thereof;
| ||
(D) not less than 15 years and not more than 60 | ||
years with respect to
900 grams or more of a substance | ||
containing morphine, or an analog thereof;
| ||
(4) 200 grams or more of any substance containing | ||
peyote, or an
analog thereof;
| ||
(5) 200 grams or more of any substance containing a | ||
derivative of
barbituric acid or any of the salts of a | ||
derivative of barbituric acid, or
an analog thereof;
| ||
(6) 200 grams or more of any substance containing | ||
amphetamine
or any salt of an optical isomer of | ||
amphetamine,
or an analog thereof;
| ||
(6.5) (blank);
| ||
(6.6) (blank);
|
(7) (A) not less than 6 years and not more than 30 | ||
years with respect
to: (i) 15 grams or more but less | ||
than 100 grams of a substance containing
lysergic acid | ||
diethylamide (LSD), or an analog thereof, or (ii) 15 or
| ||
more objects or 15 or more segregated parts of an | ||
object or objects but
less than 200 objects or 200 | ||
segregated parts of an object or objects
containing in | ||
them or having upon them any amounts of any substance
| ||
containing lysergic acid diethylamide (LSD), or an | ||
analog thereof;
| ||
(B) not less than 9 years and not more than 40 | ||
years with respect
to: (i) 100 grams or more but less | ||
than 400 grams of a substance containing
lysergic acid | ||
diethylamide (LSD), or an analog thereof, or (ii) 200 | ||
or more
objects or 200 or more segregated parts of an | ||
object or objects but less
than 600 objects or less | ||
than 600 segregated parts of an object or objects
| ||
containing in them or having upon them any amount of | ||
any substance
containing lysergic acid diethylamide | ||
(LSD), or an analog thereof;
| ||
(C) not less than 12 years and not more than 50 | ||
years with respect
to: (i) 400 grams or more but less | ||
than 900 grams of a substance containing
lysergic acid | ||
diethylamide (LSD), or an analog thereof, or (ii) 600 | ||
or more
objects or 600 or more segregated parts of an | ||
object or objects but less
than 1500 objects or 1500 |
segregated parts of an object or objects
containing in | ||
them or having upon them any amount of any substance
| ||
containing lysergic acid diethylamide (LSD), or an | ||
analog thereof;
| ||
(D) not less than 15 years and not more than 60 | ||
years with respect
to: (i) 900 grams or more of any | ||
substance containing lysergic acid
diethylamide (LSD), | ||
or an analog thereof, or (ii) 1500 or more objects or
| ||
1500 or more segregated parts of an object or objects | ||
containing in them or
having upon them any amount of a | ||
substance containing lysergic acid
diethylamide (LSD), | ||
or an analog thereof;
| ||
(7.5) (A) not less than 6 years and not more than 30 | ||
years with respect
to:
(i) 15
grams or more but less | ||
than 100 grams of a substance listed in paragraph (1),
| ||
(2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), | ||
(21), (25), or (26) of subsection
(d) of Section 204, | ||
or an analog or derivative thereof, or (ii) 15 or more
| ||
pills, tablets, caplets, capsules, or objects but less | ||
than 200 pills, tablets,
caplets, capsules, or objects | ||
containing in them or having upon them any
amounts of | ||
any substance listed in paragraph (1), (2), (2.1), | ||
(2.2), (3), (14.1),
(19), (20), (20.1), (21), (25), or | ||
(26) of subsection (d) of Section 204, or
an analog or | ||
derivative thereof;
| ||
(B) not less than 9 years and not more than 40 |
years with respect to:
(i) 100 grams or more but less | ||
than 400 grams of a substance listed in
paragraph (1), | ||
(2), (2.1), (2.2), (3), (14.1), (19), (20),
(20.1), | ||
(21), (25), or (26) of subsection (d) of Section 204, | ||
or an analog or
derivative thereof, or (ii) 200 or more | ||
pills, tablets, caplets, capsules, or
objects but less | ||
than 600 pills, tablets, caplets, capsules, or objects
| ||
containing in them or having upon them any amount of | ||
any substance listed in
paragraph (1), (2), (2.1), | ||
(2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or | ||
(26)
of subsection (d) of Section 204, or an analog or | ||
derivative thereof;
| ||
(C) not less than 12 years and not more than 50 | ||
years with respect to:
(i) 400 grams or more but less | ||
than 900 grams of a substance listed in
paragraph (1), | ||
(2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), | ||
(21), (25), or (26)
of subsection (d) of Section 204, | ||
or an analog or derivative thereof,
or (ii) 600 or more | ||
pills, tablets, caplets, capsules, or objects but less | ||
than
1,500 pills, tablets, caplets, capsules, or | ||
objects
containing in them or having upon them any | ||
amount of any substance listed in
paragraph (1), (2), | ||
(2.1), (2.2), (3), (14.1), (19), (20), (20.1), (21), | ||
(25), or (26)
of subsection (d) of Section 204, or an | ||
analog or derivative thereof;
| ||
(D) not less than 15 years and not more than 60 |
years with respect to:
(i) 900 grams or more of any | ||
substance listed in paragraph (1), (2), (2.1),
(2.2), | ||
(3), (14.1), (19), (20), (20.1), (21), (25), or (26) of | ||
subsection (d) of
Section 204, or an analog or | ||
derivative thereof, or (ii) 1,500 or more pills,
| ||
tablets, caplets, capsules, or objects containing in | ||
them or having upon them
any amount
of a substance | ||
listed in paragraph (1), (2), (2.1), (2.2), (3), | ||
(14.1), (19),
(20), (20.1), (21), (25), or (26)
of | ||
subsection (d) of Section 204, or an analog or | ||
derivative thereof;
| ||
(8) 30 grams or more of any substance containing | ||
pentazocine or any of
the salts, isomers and salts of | ||
isomers of pentazocine, or an analog thereof;
| ||
(9) 30 grams or more of any substance containing | ||
methaqualone or any of
the salts, isomers and salts of | ||
isomers of methaqualone, or an analog thereof;
| ||
(10) 30 grams or more of any substance containing | ||
phencyclidine or any
of the salts, isomers and salts of | ||
isomers of phencyclidine (PCP),
or an analog thereof;
| ||
(10.5) 30 grams or more of any substance containing | ||
ketamine
or any of the salts, isomers and salts of isomers | ||
of ketamine,
or an analog thereof;
| ||
(11) 200 grams or more of any substance containing any | ||
other controlled
substance classified in Schedules I or II, | ||
or an analog thereof, which is
not otherwise included in |
this subsection.
| ||
(b) Any person sentenced with respect to violations of | ||
paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) | ||
involving
100 grams or
more of the
controlled substance named | ||
therein, may in addition to the penalties
provided therein, be | ||
fined an amount not more than $500,000 or the full
street value | ||
of the controlled or counterfeit substance or controlled | ||
substance
analog, whichever is greater. The term "street value" | ||
shall have the
meaning ascribed in Section 110-5 of the Code of | ||
Criminal Procedure of
1963. Any person sentenced with respect | ||
to any other provision of
subsection (a), may in addition to | ||
the penalties provided therein, be fined
an amount not to | ||
exceed $500,000. | ||
(b-1) Excluding violations of this Act when the controlled | ||
substance is fentanyl, any person sentenced to a term of | ||
imprisonment with respect to violations of Section 401, 401.1, | ||
405, 405.1, 405.2, or 407, when the substance containing the | ||
controlled substance contains any amount of fentanyl, 3 years | ||
shall be added to the term of imprisonment imposed by the | ||
court, and the maximum sentence for the offense shall be | ||
increased by 3 years.
| ||
(c) Any person who violates this Section with regard to the
| ||
following amounts of controlled or counterfeit substances
or | ||
controlled substance analogs, notwithstanding any of the | ||
provisions of
subsections (a), (b), (d), (e), (f), (g) or (h) | ||
to the
contrary, is guilty of a Class 1 felony. The fine for |
violation of this
subsection (c) shall not be more than | ||
$250,000:
| ||
(1) 1 gram or more but less than 15 grams of any
| ||
substance containing heroin, or an analog thereof;
| ||
(1.5) 1 gram or more but less than 15 grams of any | ||
substance containing fentanyl, or an analog thereof;
| ||
(2) 1 gram or more but less than 15
grams of any | ||
substance containing cocaine, or an analog thereof;
| ||
(3) 10 grams or more but less than 15 grams of any | ||
substance
containing morphine, or an analog thereof;
| ||
(4) 50 grams or more but less than 200 grams of any | ||
substance
containing peyote, or an analog thereof;
| ||
(5) 50 grams or more but less than 200 grams of any | ||
substance
containing a derivative of barbituric acid or any | ||
of the salts of a
derivative of barbituric acid, or an | ||
analog thereof;
| ||
(6) 50 grams or more but less than 200 grams of any | ||
substance
containing amphetamine or any salt of an optical | ||
isomer
of amphetamine, or an analog thereof;
| ||
(6.5) (blank);
| ||
(7) (i) 5 grams or more but less than 15 grams of any | ||
substance
containing lysergic acid diethylamide (LSD), or | ||
an analog thereof,
or (ii)
more than 10 objects or more | ||
than 10 segregated parts of an object or objects
but less | ||
than 15 objects or less than 15 segregated parts of an | ||
object
containing in them or having upon them any amount of |
any substance
containing lysergic acid diethylamide (LSD), | ||
or an analog thereof;
| ||
(7.5) (i) 5 grams or more but less than 15 grams of any | ||
substance listed
in paragraph (1), (2), (2.1), (2.2), (3), | ||
(14.1), (19), (20), (20.1), (21), (25), or
(26) of | ||
subsection (d) of Section 204, or an analog or derivative | ||
thereof, or
(ii) more than 10 pills, tablets, caplets, | ||
capsules, or objects but less than
15 pills, tablets, | ||
caplets, capsules, or objects containing in them or having
| ||
upon them any amount of any substance listed in paragraph | ||
(1), (2), (2.1),
(2.2), (3), (14.1), (19), (20), (20.1), | ||
(21), (25), or (26) of subsection (d) of
Section 204, or an | ||
analog or derivative thereof;
| ||
(8) 10 grams or more but less than 30 grams of any | ||
substance
containing pentazocine or any of the salts, | ||
isomers and salts of isomers of
pentazocine, or an analog | ||
thereof;
| ||
(9) 10 grams or more but less than 30 grams of any | ||
substance
containing methaqualone or any of the salts, | ||
isomers and salts of isomers
of methaqualone, or an analog | ||
thereof;
| ||
(10) 10 grams or more but less than 30 grams of any | ||
substance
containing phencyclidine or any of the salts, | ||
isomers and salts of isomers
of phencyclidine (PCP), or an | ||
analog thereof;
| ||
(10.5) 10 grams or more but less than 30 grams of any |
substance
containing ketamine or any of the salts, isomers | ||
and salts of
isomers of ketamine, or an analog thereof;
| ||
(11) 50 grams or more but less than 200 grams of any | ||
substance
containing a substance classified in Schedules I | ||
or II, or an analog
thereof, which is not otherwise | ||
included in this subsection.
| ||
(c-5) (Blank).
| ||
(d) Any person who violates this Section with regard to any | ||
other
amount of a controlled or counterfeit substance | ||
classified in
Schedules I or II, or an analog thereof, which is | ||
(i) a narcotic
drug, (ii) lysergic acid diethylamide (LSD) or | ||
an analog thereof, or
(iii) any
substance containing | ||
amphetamine or fentanyl or any salt or optical
isomer of | ||
amphetamine or fentanyl, or an analog thereof, or (iv) any
| ||
substance containing N-Benzylpiperazine (BZP) or any salt or | ||
optical
isomer of N-Benzylpiperazine (BZP), or an analog | ||
thereof, is guilty
of a Class 2 felony. The fine for violation | ||
of this subsection (d) shall
not be more than $200,000.
| ||
(d-5) (Blank).
| ||
(e) Any person who violates this Section with regard to any | ||
other
amount of a controlled substance other than | ||
methamphetamine or counterfeit substance classified in
| ||
Schedule I or II, or an analog thereof, which substance is not
| ||
included under subsection (d) of this Section, is
guilty of a | ||
Class 3 felony. The fine for violation of this subsection (e)
| ||
shall not be more than $150,000.
|
(f) Any person who violates this Section with regard to any | ||
other
amount of a controlled or counterfeit substance | ||
classified in
Schedule III is guilty of a Class 3 felony. The | ||
fine for violation of
this subsection (f) shall not be more | ||
than $125,000.
| ||
(g) Any person who violates this Section with regard to any | ||
other
amount of a controlled or counterfeit substance | ||
classified
in Schedule IV is guilty of a Class 3 felony. The | ||
fine for violation of
this subsection (g) shall not be more | ||
than $100,000.
| ||
(h) Any person who violates this Section with regard to any | ||
other
amount of a controlled or counterfeit substance | ||
classified in
Schedule V is guilty of a Class 3 felony. The | ||
fine for violation of this
subsection (h) shall not be more | ||
than $75,000.
| ||
(i) This Section does not apply to the manufacture, | ||
possession or
distribution of a substance in conformance with | ||
the provisions of an approved
new drug application or an | ||
exemption for investigational use within the
meaning of Section | ||
505 of the Federal Food, Drug and Cosmetic Act.
| ||
(j) (Blank).
| ||
(Source: P.A. 94-556, eff. 9-11-05; 95-259, eff. 8-17-07.)
| ||
(720 ILCS 570/402) (from Ch. 56 1/2, par. 1402)
| ||
Sec. 402. Except as otherwise authorized by this Act, it is | ||
unlawful for
any person knowingly to possess a controlled or |
counterfeit substance or controlled substance analog.
A | ||
violation of this Act with respect to each of the controlled | ||
substances
listed herein constitutes a single and separate | ||
violation of this Act. For purposes of this Section, | ||
"controlled substance analog" or "analog"
means a substance
| ||
which is intended for human consumption, other than a | ||
controlled substance,
that has a chemical structure | ||
substantially similar to that of a controlled
substance in | ||
Schedule I or II, or that was specifically designed to produce
| ||
an effect substantially similar to that of a controlled | ||
substance in Schedule
I or II. Examples of chemical classes in | ||
which controlled substance analogs
are found include, but are | ||
not limited to, the following: phenethylamines,
N-substituted | ||
piperidines, morphinans, ecgonines, quinazolinones, | ||
substituted
indoles, and arylcycloalkylamines. For purposes of | ||
this Act, a controlled
substance analog shall be treated in the | ||
same manner as the controlled
substance to which it is | ||
substantially similar.
| ||
(a) Any person who violates this Section with respect to | ||
the following
controlled or counterfeit substances and | ||
amounts, notwithstanding any of the
provisions of subsections | ||
(c) and (d) to the
contrary, is guilty of a Class 1 felony and | ||
shall, if sentenced to a term
of imprisonment, be sentenced as | ||
provided in this subsection (a) and fined
as provided in | ||
subsection (b):
| ||
(1) (A) not less than 4 years and not more than 15 |
years with respect
to 15 grams or more but less than | ||
100 grams of a substance containing heroin;
| ||
(B) not less than 6 years and not more than 30 | ||
years with respect to 100
grams or more but less than | ||
400 grams of a substance containing heroin;
| ||
(C) not less than 8 years and not more than 40 | ||
years with respect to 400
grams or more but less than | ||
900 grams of any substance containing heroin;
| ||
(D) not less than 10 years and not more than 50 | ||
years with respect to
900 grams or more of any | ||
substance containing heroin;
| ||
(2) (A) not less than 4 years and not more than 15 | ||
years with respect
to 15 grams or more but less than | ||
100 grams of any substance containing
cocaine;
| ||
(B) not less than 6 years and not more than 30 | ||
years with respect to 100
grams or more but less than | ||
400 grams of any substance containing cocaine;
| ||
(C) not less than 8 years and not more than 40 | ||
years with respect to 400
grams or more but less than | ||
900 grams of any substance containing cocaine;
| ||
(D) not less than 10 years and not more than 50 | ||
years with respect to
900 grams or more of any | ||
substance containing cocaine;
| ||
(3) (A) not less than 4 years and not more than 15 | ||
years with respect
to 15 grams or more but less than | ||
100 grams of any substance containing
morphine;
|
(B) not less than 6 years and not more than 30 | ||
years with respect to 100
grams or more but less than | ||
400 grams of any substance containing morphine;
| ||
(C) not less than 6 years and not more than 40 | ||
years with respect to 400
grams or more but less than | ||
900 grams of any substance containing morphine;
| ||
(D) not less than 10 years and not more than 50 | ||
years with respect to
900 grams or more of any | ||
substance containing morphine;
| ||
(4) 200 grams or more of any substance containing | ||
peyote;
| ||
(5) 200 grams or more of any substance containing a | ||
derivative of
barbituric acid or any of the salts of a | ||
derivative of barbituric acid;
| ||
(6) 200 grams or more of any substance containing | ||
amphetamine or any salt
of an optical isomer of | ||
amphetamine;
| ||
(6.5) (blank);
| ||
(7) (A) not less than 4 years and not more than 15 | ||
years with respect
to: (i) 15 grams or more but less | ||
than 100 grams of any substance containing
lysergic | ||
acid diethylamide (LSD), or an analog thereof, or (ii) | ||
15 or
more objects or 15 or more segregated parts of an | ||
object or objects but
less than 200 objects or 200 | ||
segregated parts of an object or objects
containing in | ||
them or having upon them any amount of any substance
|
containing lysergic acid diethylamide (LSD), or an | ||
analog thereof;
| ||
(B) not less than 6 years and not more than 30 | ||
years with respect
to: (i) 100 grams or more but less | ||
than 400 grams of any substance
containing lysergic | ||
acid diethylamide (LSD), or an analog thereof, or (ii)
| ||
200 or more objects or 200 or more segregated parts of | ||
an object or objects
but less than 600 objects or less | ||
than 600 segregated parts of an object or
objects | ||
containing in them or having upon them any amount of | ||
any substance
containing lysergic acid diethylamide | ||
(LSD), or an analog thereof;
| ||
(C) not less than 8 years and not more than 40 | ||
years with respect
to: (i) 400 grams or more but less | ||
than 900 grams of any substance
containing lysergic | ||
acid diethylamide (LSD), or an analog thereof, or (ii)
| ||
600 or more objects or 600 or more segregated parts of | ||
an object or objects
but less than 1500 objects or 1500 | ||
segregated parts of an object or objects
containing in | ||
them or having upon them any amount of any substance
| ||
containing lysergic acid diethylamide (LSD), or an | ||
analog thereof;
| ||
(D) not less than 10 years and not more than 50 | ||
years with respect
to: (i) 900 grams or more of any | ||
substance containing lysergic acid
diethylamide (LSD), | ||
or an analog thereof, or (ii) 1500 or more objects or
|
1500 or more segregated parts of an object or objects | ||
containing in them or
having upon them any amount of a | ||
substance containing lysergic acid
diethylamide (LSD), | ||
or an analog thereof;
| ||
(7.5) (A) not less than 4 years and not more than 15 | ||
years with respect
to: (i) 15
grams or more but
less | ||
than 100 grams of any substance listed in paragraph | ||
(1), (2), (2.1), (2.2), (3),
(14.1), (19),
(20), | ||
(20.1), (21), (25), or (26) of subsection (d) of | ||
Section 204, or an
analog or derivative
thereof, or | ||
(ii) 15 or more pills, tablets, caplets, capsules, or | ||
objects but
less than 200 pills,
tablets, caplets, | ||
capsules, or objects containing in them or having upon | ||
them
any amount of any
substance listed in paragraph | ||
(1), (2), (2.1), (2.2), (3), (14.1), (19), (20), | ||
(20.1),
(21), (25), or (26) of
subsection (d) of | ||
Section 204, or an analog or derivative thereof;
| ||
(B) not less than 6 years and not more than 30 | ||
years with respect to: (i)
100
grams or more but
less | ||
than 400 grams of any substance listed in paragraph | ||
(1), (2), (2.1), (2.2), (3),
(14.1), (19), (20),
| ||
(20.1), (21), (25), or (26) of subsection (d) of | ||
Section 204, or an analog or
derivative thereof, or
| ||
(ii) 200 or more pills, tablets, caplets, capsules, or | ||
objects but less than
600
pills, tablets,
caplets, | ||
capsules, or objects containing in them or having upon |
them any amount
of any
substance
listed in paragraph | ||
(1), (2), (2.1), (2.2), (3), (14.1), (19), (20), | ||
(20.1), (21),
(25), or (26) of subsection
(d) of | ||
Section 204, or an analog or derivative thereof;
| ||
(C) not less than 8 years and not more than 40 | ||
years with respect to: (i)
400
grams or more but
less | ||
than 900 grams of any substance listed in paragraph | ||
(1), (2), (2.1), (2.2), (3),
(14.1), (19), (20),
| ||
(20.1), (21), (25), or (26) of subsection (d) of | ||
Section 204, or an analog or
derivative thereof,
or | ||
(ii) 600 or more pills, tablets, caplets, capsules, or | ||
objects but less than
1,500 pills, tablets,
caplets, | ||
capsules, or objects containing in them or having upon | ||
them any amount
of any
substance listed in paragraph | ||
(1), (2), (2.1), (2.2), (3), (14.1), (19), (20), | ||
(20.1),
(21), (25), or (26) of
subsection (d) of | ||
Section 204, or an analog or derivative thereof;
| ||
(D) not less than 10 years and not more than 50 | ||
years with respect to:
(i)
900 grams or more of
any | ||
substance listed in paragraph (1), (2), (2.1), (2.2), | ||
(3), (14.1), (19), (20),
(20.1), (21), (25), or (26)
of | ||
subsection (d) of Section 204, or an analog or | ||
derivative thereof, or (ii)
1,500 or more pills,
| ||
tablets, caplets, capsules, or objects containing in | ||
them or having upon them
any amount of a
substance | ||
listed in paragraph (1), (2), (2.1), (2.2), (3), |
(14.1), (19), (20), (20.1),
(21), (25), or (26) of
| ||
subsection (d) of Section 204, or an analog or | ||
derivative thereof;
| ||
(8) 30 grams or more of any substance containing | ||
pentazocine or any of
the salts, isomers and salts of | ||
isomers of pentazocine, or an analog thereof;
| ||
(9) 30 grams or more of any substance containing | ||
methaqualone or any
of the salts, isomers and salts of | ||
isomers of methaqualone;
| ||
(10) 30 grams or more of any substance containing | ||
phencyclidine or any
of the salts, isomers and salts of | ||
isomers of phencyclidine (PCP);
| ||
(10.5) 30 grams or more of any substance containing | ||
ketamine or any of
the salts, isomers and salts of isomers | ||
of ketamine;
| ||
(11) 200 grams or more of any substance containing any | ||
substance
classified as a narcotic drug in Schedules I or | ||
II, or an analog thereof, which is not otherwise
included | ||
in this subsection.
| ||
(b) Any person sentenced with respect to violations of | ||
paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) | ||
involving 100
grams or more of the
controlled substance named | ||
therein, may in addition to the penalties
provided therein, be | ||
fined an amount not to exceed $200,000 or the full
street value | ||
of the controlled or counterfeit substances, whichever is
| ||
greater. The term "street value" shall have the meaning
|
ascribed in Section 110-5 of the Code of Criminal Procedure of | ||
1963. Any
person sentenced with respect to any other provision | ||
of subsection (a), may
in addition to the penalties provided | ||
therein, be fined an amount not to
exceed $200,000.
| ||
(c) Any person who violates this Section with regard to an | ||
amount
of a controlled substance other than methamphetamine or | ||
counterfeit substance not set forth in
subsection (a) or (d) is | ||
guilty of a Class 4 felony. The fine for a
violation punishable | ||
under this subsection (c) shall not be more
than $25,000.
| ||
(d) Any person who violates this Section with regard to any | ||
amount of
anabolic steroid is guilty of a Class C misdemeanor
| ||
for the first offense and a Class B misdemeanor for a | ||
subsequent offense
committed within 2 years of a prior | ||
conviction.
| ||
(Source: P.A. 94-324, eff. 7-26-05; 94-556, eff. 9-11-05; | ||
95-331, eff. 8-21-07.)
|